We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Considering Overhaul of OTC Review Process
After operating its OTC drug review process largely unchanged for 40 years, the FDA has concluded the process needs an overhaul to address long-standing problems.